i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Encouraging Phase III Topline Results from PANAMO Trial of Vilobelimab in Severe COVID-19 Patients

Mar 31, 2022

Time to read 4 Minutes

Download PDF

Back